Figure 3.
The incidence of renal disease progression during the follow-up period. *p = 0.022 and **p = 0.003 for the TwHF and valsartan groups, respectively.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.